Skip to content
HUMHumana

What Is HUM Fair Value?

Humana (HUM) fair value estimate using multiple valuation models, updated daily.

As of October 14, 2026, Humana (HUM) has a composite fair value estimate of $276.18 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $427.40, suggesting the stock is overvalued by 35.4%.

Data as of October 14, 2026 (today)

Composite Fair Value

Overvalued3 of 4 models

$276.18

vs. current price of $427.40(-35.4%)

Undervalued$276.18Overvalued
$427.40

How Is HUM Fair Value Calculated?

Four independent models estimate what HUM is worth. Each uses different inputs and assumptions. The composite blends them by weight.

HUM Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

41% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$404.26

-5.4%

Fair Value

Inputs used

FCF: 1.9BGrowth: 5.0%Discount: 8%

DDM (Dividend Discount Model)

0% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

N/A

This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.

HUM Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

29% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$181.58

-57.5%

Overvalued

Inputs used

EPS: $9.16Book Value: $160.00

PEG (Price/Earnings to Growth)

29% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$91.59

-78.6%

Overvalued

Inputs used

EPS: $9.16Growth: 5.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$404.26Fair Value

Current price $427.40 is 5.4% above this estimate

CheapFair ValueExpensive
5.0%
0.0%30.0%
7.6%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.04B$1.89B
Year 2$2.14B$1.85B
Year 3$2.25B$1.81B
Year 4$2.36B$1.76B
Year 5$2.48B$1.72B
Year 6$2.60B$1.68B
Year 7$2.73B$1.64B
Year 8$2.87B$1.60B
Year 9$3.01B$1.56B
Year 10$3.16B$1.53B
Terminal Value$64.10B$30.94B

What Are HUM's Key Financial Metrics?

Earnings & Growth

Current Price

$427.40

EPS (TTM)

$10.58

Forward P/E

25.0

Profit Margin

0.9%

Cash & Balance Sheet

Free Cash Flow

1.9B

EBITDA

3.6B

Book Value

$160.00

Total Debt

14.7B

What Do Analysts Say About HUM?

Low

$280.00

Average

$465.13

High

$596.00

Upside

+8.8%

Current $427.40Avg Target $465.13Buy24 analysts

HUM Fair Value FAQ

What is the fair value of HUM?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), HUM's estimated fair value is $276.18. The stock is currently trading at $427.40, which makes it overvalued by our analysis.

How is HUM's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is HUM overvalued or undervalued?

Based on our analysis, HUM is overvalued. The current price of $427.40 is 35.4% above our estimated fair value of $276.18.

What do Wall Street analysts say about HUM?

24 analysts cover Humana with a consensus rating of "Buy." The average price target is $465.13, ranging from $280.00 to $596.00. This implies 8.8% upside from the current price.